title: [Bisphosphonates: indications in bone diseases other than osteoporosis].
abstract: OBJECTIVE
  Report of bisphosphonates indications for osseous diseases other than osteoporosis.
  
  
  METHODS
  Narrative review of the literature.
  
  
  RESULTS
  Bisphosphonates represent a new medication which is increasingly used. Besides osteoporosis, it is indicated as first choice in different bone diseases such as Paget's disease and the prevention of bone complications in tumoral osteolysis. Bisphosphonates' efficiency has been proven in other pathologies: the fibrous dysplasia and the osteogenesis imperfecta. More over, many studies are driven having for goal to show the efficiency of bisphosphonates in the algoneurodystrophy, non corticosteroid-treated osteoporosis in chronic inflammatory rheumatism and aseptic osteonecrosis.
  
  
  CONCLUSIONS
  Bisphosphonates are a powerful inhibition of osseous resoption frestable indicated for osteoporosis. Their indications were retended to paget's disease, malignant hypercalcemia, and osseous complications of malignant osterlysis.
authors.affiliation: Universite Tunis, El Manar, Tunisie.
authors.forename: Leila Cheikhrouhou
authors.initials: LC
authors.lastname: Abdelmoula
authors.forename: Rim
authors.initials: R
authors.lastname: Ben M'barek
authors.forename: Chiraz
authors.initials: C
authors.lastname: Ben Hadj Yahia
authors.forename: Raoudha
authors.initials: R
authors.lastname: Tekaya
authors.forename: Nadia
authors.initials: N
authors.lastname: Testouri
authors.forename: Lilia
authors.initials: L
authors.lastname: Chaabouni
authors.forename: Rafik
authors.initials: R
authors.lastname: Zouari
mesh_terms: D001847:Bone Diseases / Q000188:drug therapy*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy
chemical_list: D004164:Diphosphonates